These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 6465859

  • 1. Adjuvant immunotherapy of N-[4(5-nitro-2-furyl)-2-thiazolyl]-formamide-induced bladder tumors.
    Ibraheim EH, El Kappany H, Nigam VN, Brailovsky CA, Madarnas P, Elhilali MM.
    Anticancer Res; 1984; 4(3):209-13. PubMed ID: 6465859
    [Abstract] [Full Text] [Related]

  • 2. The antitumour activity of maltose tetrapalmitate compared with other immunoadjuvants, and its effectiveness after tumour surgery.
    El Kappany H, Chopra C, Nigam VN, Brailovsky CA, Elhilali M.
    Br J Cancer; 1980 Nov; 42(5):703-11. PubMed ID: 7459208
    [Abstract] [Full Text] [Related]

  • 3. A comparative study of the intravesical MTP and BCG treatment of transplantable bladder cancer.
    Elhilali MM, Ibrahim EH, Nigam VN, Brailovsky CA, Madarnas P.
    J Urol; 1983 Jun; 129(6):1265-9. PubMed ID: 6854814
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Low susceptibility of analbuminemic rats to induction of bladder cancer by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Hosaka Y, Muramatsu M, Matsushima T, Niijima T, Nagase S.
    Jpn J Cancer Res; 1985 Jul; 76(7):577-82. PubMed ID: 3928553
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparative antitumor effects of Corynebacterium parvum, Bordetella pertussis, Bacillus Calmette-Guérin, and levamisole alone or in combination with cyclophosphamide in the CaD2 murine mammary adenocarcinoma system.
    Purnell DM, Bartlett GL, Kreider JW, Biro TG, Kontra J.
    Cancer Res; 1979 Dec; 39(12):4838-42. PubMed ID: 498111
    [Abstract] [Full Text] [Related]

  • 14. Immune modifiers in the treatment of bladder cancer.
    Morales A.
    Prog Clin Biol Res; 1990 Dec; 350():25-33. PubMed ID: 2201046
    [No Abstract] [Full Text] [Related]

  • 15. Effect of aspirin on urinary bladder carcinogenesis initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats.
    Cohen SM, Hasegawa R, Sakata T, Johansson SL.
    Cancer Res; 1989 Jan 15; 49(2):372-7. PubMed ID: 2491954
    [Abstract] [Full Text] [Related]

  • 16. A bladder tumor model response to immunotherapy.
    deKernion JB, Ramming KP, Fraser K.
    Natl Cancer Inst Monogr; 1978 Dec 15; (49):333. PubMed ID: 748789
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of cortisone-heparin and cortisone-maltose tetrapalmitate therapies against rodent tumors. I. Biological studies.
    Benrezzak O, Madarnas P, Pageau R, Nigam VN, Elhilali MM.
    Anticancer Res; 1989 Dec 15; 9(6):1883-7. PubMed ID: 2627134
    [Abstract] [Full Text] [Related]

  • 18. Effect of L-tryptophan and sodium saccharin on urinary tract carcinogenesis initiated by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Fukushima S, Friedell GH, Jacobs JB, Cohen SM.
    Cancer Res; 1981 Aug 15; 41(8):3100-3. PubMed ID: 7248968
    [Abstract] [Full Text] [Related]

  • 19. Neovascularization in rats during urinary bladder carcinogenesis induced by N-[4-(5-Nitro-2-furyl)-2-thiazolyl]formamide.
    Cohen SM, Tatematsu M, Shinohara Y, Nakanishi K, Ito N.
    J Natl Cancer Inst; 1980 Jul 15; 65(1):145-8. PubMed ID: 6930511
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.